X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (134) 134
humans (129) 129
male (92) 92
middle aged (89) 89
female (84) 84
hematology (83) 83
adult (82) 82
aged (54) 54
oncology (46) 46
adolescent (45) 45
prognosis (36) 36
medicine & public health (29) 29
leukemia, myeloid, acute - drug therapy (28) 28
acute myeloid leukemia (27) 27
cancer (27) 27
treatment outcome (26) 26
chemotherapy (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
retrospective studies (23) 23
young adult (22) 22
recurrence (21) 21
survival rate (21) 21
aged, 80 and over (20) 20
acute myelogenous leukemia (19) 19
remission induction (19) 19
hematopoietic stem cell transplantation (18) 18
leukemia, myeloid, acute - genetics (18) 18
mutation (18) 18
research (18) 18
japan (17) 17
leukemia, myeloid, acute - mortality (17) 17
leukemia, myeloid, acute - therapy (17) 17
analysis (16) 16
survival analysis (16) 16
abridged index medicus (15) 15
disease-free survival (15) 15
transplantation, homologous (15) 15
leukemia (14) 14
maintenance intensification therapy (13) 13
aml (12) 12
chemistry (12) 12
dose-response relationship, drug (12) 12
leukemia, myeloid, acute - diagnosis (12) 12
leukocyte count (12) 12
metallurgy (12) 12
oncology, experimental (12) 12
relapse (12) 12
survival (12) 12
therapy (12) 12
acute disease (11) 11
cytarabine (11) 11
cytarabine - administration & dosage (11) 11
trial (11) 11
acute promyelocytic leukemia (10) 10
antineoplastic agents - therapeutic use (10) 10
bone-marrow-transplantation (10) 10
heterocyclic compounds (10) 10
individualized induction therapy (10) 10
medical colleges (10) 10
mutations (10) 10
organic chemistry (10) 10
risk factors (10) 10
stem-cell transplantation (10) 10
transplantation (10) 10
adults (9) 9
diagnosis (9) 9
follow-up studies (9) 9
leukemia, promyelocytic, acute - drug therapy (9) 9
multivariate analysis (9) 9
time factors (9) 9
acute myeloid-leukemia (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
classification (8) 8
genetic aspects (8) 8
internal medicine (8) 8
physics (8) 8
calculating (7) 7
computing (7) 7
consolidation therapy (7) 7
counting (7) 7
cytarabine - therapeutic use (7) 7
cytosine-arabinoside (7) 7
daunorubicin - administration & dosage (7) 7
electric digital data processing (7) 7
health aspects (7) 7
hematology, oncology and palliative medicine (7) 7
karyotyping (7) 7
myelodysplastic syndromes (7) 7
antineoplastic agents - adverse effects (6) 6
child (6) 6
daunorubicin (6) 6
expression (6) 6
gene mutations (6) 6
group-b (6) 6
idarubicin - administration & dosage (6) 6
immunophenotyping (6) 6
impact (6) 6
induction (6) 6
leukemia, myeloid, acute - pathology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Hematology, ISSN 0925-5710, 9/2017, Volume 106, Issue 3, pp. 310 - 325
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12185-017-2303-4 Byline:... 
Medicine & Public Health | Hematology | Oncology | GRANULOCYTIC-SARCOMA | HEMATOLOGY | Tumors | Myeloid leukemia | Leukemia | Lymphoid tissue | Tissues | Acute myeloid leukemia | Hemopoiesis | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2004, Volume 101, Issue 29, pp. 10554 - 10559
Fluorescence resonance energy transfer (FRET) technology has been used to develop genetically encoded fluorescent indicators for various cellular functions.... 
Brain | Biological Sciences | Complementary DNA | Transgenic animals | Imaging | Fluorescence | Dynamic range | HeLa cells | Cell membranes | Titration | Chromophores | CALMODULIN | MULTIDISCIPLINARY SCIENCES | Biochemistry | Optimization
Journal Article
Nature, ISSN 0028-0836, 10/2011, Volume 478, Issue 7367, pp. 64 - 69
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 10/2013, Volume 54, Issue 10, pp. 1633 - 1642
Journal Article
Nature Genetics, ISSN 1061-4036, 11/2015, Volume 47, Issue 11, pp. 1304 - 1315
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 2014, Volume 55, Issue 1, pp. 31 - 41
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2017, Volume 49, Issue 2, pp. 204 - 212
Journal Article
Nature Genetics, ISSN 1061-4036, 10/2013, Volume 45, Issue 10, pp. 1232 - 1237
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 04/2012, Volume 70 Suppl 2, p. 399
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 2012, Volume 70, pp. 399 - 408
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2006, Volume 24, Issue 3, pp. 460 - 466
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 07/2017, Volume 66, Issue 7, pp. 851 - 863
Wilms' tumor 1 (WT1) is a promising target of new immunotherapies for acute myeloid leukemia (AML) as well as for other cancers. OCV-501 is a helper peptide... 
Helper peptide | OCV-501 | Cancer vaccine | WT1 | Acute myeloid leukemia | Immunotherapy | CD4(+) T-CELLS | INDUCTION | IMMUNOLOGY | CANCER | TUMOR-ANTIGEN | RESPONSES | MELANOMA | ONCOLOGY | EPITOPE LONG PEPTIDE | LYMPHOCYTES | HLA-A2 Antigen - genetics | Cancer Vaccines - pharmacology | Humans | Middle Aged | Male | Th1 Cells - immunology | Dose-Response Relationship, Drug | T-Lymphocytes, Cytotoxic - drug effects | WT1 Proteins - pharmacology | WT1 Proteins - immunology | Aged, 80 and over | Female | Leukemia, Myeloid, Acute - therapy | T-Lymphocytes, Cytotoxic - immunology | Th1 Cells - drug effects | WT1 Proteins - administration & dosage | Cancer Vaccines - administration & dosage | Vaccines, Subunit - immunology | HLA-DR beta-Chains - genetics | Remission Induction | Cancer Vaccines - immunology | Maximum Tolerated Dose | Vaccines, Subunit - pharmacology | Lymphocyte Activation - drug effects | Vaccines, Subunit - administration & dosage | Cell Line, Tumor | Aged | Cohort Studies | Peptides | Oncology, Experimental | Clinical trials | Research | Vaccines | T cells | Cancer | Cytolytic activity | Hypersensitivity (delayed) | Myeloid leukemia | Leukemia | Hypersensitivity | Cytotoxicity | Leukocytes (mononuclear) | Pharmacology | Lymphocytes T | In vitro testing | Blast | Wilms' tumor | Patients | WT1 protein | Immunology | Lymphocytes B | Lymphocytes | Peripheral blood mononuclear cells | Remission | Histocompatibility antigen HLA | Blast cells | Index Medicus | Original
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 01/2012, Volume 53, Issue 1, pp. 39 - 50
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 8/2019, Volume 110, Issue 2, pp. 127 - 128
Byline: Tatsuya Konishi (1,2), Hideharu Muto (1), Ryoko Sakuma (3), Shuichi Miyawaki (1), Kazuteru Ohashi (2), Noriko Doki (2), Junji Tomiyama (1) Keywords:... 
Autosomal dominant inheritance | Medicine & Public Health | Hematology | Benign anomaly | Oncology | Pelger-Huët anomaly | Hypolobulated neutrophils | HEMATOLOGY | Pelger-Huet anomaly
Journal Article